Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001948437 | SCV002199792 | uncertain significance | not provided | 2023-01-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with SLC4A1-related conditions. This variant is present in population databases (rs774121522, gnomAD 0.01%). This variant, c.256_258del, results in the deletion of 1 amino acid(s) of the SLC4A1 protein (p.Glu86del), but otherwise preserves the integrity of the reading frame. |
Revvity Omics, |
RCV001948437 | SCV004237338 | uncertain significance | not provided | 2023-03-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005016875 | SCV005642261 | uncertain significance | BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP--WALDNER TYPE; BLOOD GROUP--FROESE; BLOOD GROUP--WRIGHT ANTIGEN; Southeast Asian ovalocytosis; Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; Cryohydrocytosis; Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal, 4, with hemolytic anemia; Malaria, susceptibility to | 2024-03-27 | criteria provided, single submitter | clinical testing |